Close

Solid Biosciences (SLDB) Announces Acquisition of AavantiBio and Concurrent $75 Million Private Placement

Go back to Solid Biosciences (SLDB) Announces Acquisition of AavantiBio and Concurrent $75 Million Private Placement

JPMorgan Upgrades Solid Biosciences (SLDB) to Neutral

September 30, 2022 10:45 AM EDT

JPMorgan analyst Anupam Rama upgraded Solid Biosciences (NASDAQ: SLDB) from Underweight to Neutral.

For an analyst ratings summary and ratings history on Solid Biosciences click here. For more ratings news on Solid Biosciences click here.

Shares of Solid Biosciences closed at $0.47 yesterday.

... More